Activities of Ertapenem, a New Long-Acting Carbapenem, against Penicillin-Sensitive or -Resistant Pneumococci in Experimental Meningitis

The penetration of ertapenem, a new carbapenem with a long half-life, reached 7.1 and 2.4% into inflamed and noninflamed meninges, respectively. Ertapenem had excellent antibacterial activity in the treatment of experimental meningitis due to penicillin-sensitive and -resistant pneumococci, leading...

全面介紹

書目詳細資料

發表在:	Antimicrob Agents Chemother
Principais autores:	Cottagnoud, P., Pfister, M., Cottagnoud, M., Acosta, F., Täuber, M. G.
格式:	Artigo
語言:	Inglês
出版:	American Society for Microbiology (ASM) 2003
主題:	Experimental Therapeutics
在線閱讀:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC155819/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12760871/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.6.1943-1947.2003
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!